ppar research سال:2012 - دوره:

Fa | Ar | En


ppar research
سال:2012 - دوره: - شماره:0

A role for peroxisome proliferator-activated receptors in the immunopathology of schistosomiasis? AS601245,an anti-inflammatory JNK inhibitor,and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile in CaCo-2 colon cancer cells Altered peroxisome-proliferator activated receptors expression in human endometrial cancer Anti- and protumorigenic effects of PPARγ in lung cancer progression: A double-edged sword Antioxidant stress and anti-inflammation of PPAR α on warm hepatic ischemia-reperfusion injury Cinchonine prevents high-fat-diet-induced obesity through downregulation of adipogenesis and adipose inflammation Conditional expression of human PPARδ and a dominant negative variant of hPPARδ in vivo Coordinated regulation of PPAR γ expression and activity through control of chromatin structure in adipogenesis and obesity Correlations among PPARγ,DNMT1,and DNMT3B expression levels and pancreatic cancer Effect of 2,4-thiazolidinedione on Limousin cattle growth and on muscle and adipose tissue metabolism Effect of pioglitazone on the fructose-induced abdominal adipose tissue dysfunction Effects of PPAR ligands on leukemia Emerging PPARγ-independent role of PPARγ ligands in lung diseases Expression pattern of peroxisome proliferator-activated receptors in rat hippocampus following cerebral ischemia and reperfusion injury Fatty acid accumulation and resulting PPARα activation in fibroblasts due to trifunctional protein deficiency Fenofibrate enhances the in vitro differentiation of Foxp3 + regulatory T cells in mice Fenofibrate inhibited the differentiation of T helper 17 cells in vitro Global gene expression profiling in PPAR-γ agonist-treated kidneys in an orthologous rat model of human autosomal recessive polycystic kidney disease Hepatic cerebroside sulfotransferase is induced by PPARα activation in mice Idealized PPARγ-based therapies: Lessons from bench and bedside In vitro and in vivo characterizations of chiglitazar,a newly identified PPAR pan-agonist Leptin antagonizes peroxisome proliferator-activated receptor- γ signaling in growth plate chondrocytes Misregulation of PPAR functioning and its pathogenic consequences associated with nonalcoholic fatty liver disease in human obesity Modulation of PPAR-γ by nutraceutics as complementary treatment for obesity-related disorders and inflammatory diseases Modulation of preactivation of PPAR-β on memory and learning dysfunction and inflammatory response in the hippocampus in rats exposed to global cerebral ischemia/reperfusion New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury Nutraceuticals as ligands of PPARγ PPAR and oxidative stress: Con(β) catenating NRF2 and FOXO PPAR could contribute to the pathogenesis of hepatocellular carcinoma PPAR medicines and human disease: The ABCs of it all PPAR γ in inflammatory bowel disease PPAR γ ligands regulate noncontractile and contractile functions of airway smooth muscle: Implications for asthma therapy PPARG epigenetic deregulation and its role in colorectal tumorigenesis PPARs and HCV-related hepatocarcinoma: A mitochondrial point of view PPARs and gastrointestinal cancer PPARs in liver diseases and cancer: Epigenetic regulation by microRNAs PPARs in regulation of paraoxonases: Control of oxidative stress and inflammation pathways PPARs signaling and cancer in the gastrointestinal system PPARs: Interference with Warburg' effect and clinical anticancer trials PPARs: Regulators and translational targets in the lung PPARα activation protects against anti-thy1 nephritis by suppressing glomerular NF-κB signaling PPARα as a transcriptional regulator for detoxification of plant diet-derived unfavorable compounds PPARα-independent arterial smooth muscle relaxant effects of PPAR α agonists PPARγ activation rescues pancreatic β-cell line INS-1E from palmitate-induced endoplasmic reticulum stress through enhanced fatty acid oxidation PPARγ as a potential target to treat airway mucus hypersecretion in chronic airway inflammatory diseases PPARγ expression and function in mycobacterial infection: Roles in lipid metabolism,immunity,and bacterial killing PPARγ signaling mediates the evolution,development,homeostasis,and repair of the lung Peroxisome Proliferator-Activated Receptor Gamma and regulations by the ubiquitin-proteasome system in pancreatic cancer Peroxisome proliferator activated receptor- agonist slows the progression of hypertension,attenuates plasma interleukin-6 levels and renal inflammatory markers in angiotensin II infused mice Peroxisome proliferator-activated receptor agonists differentially regulate inhibitor of DNA binding expression in rodents and human cells Peroxisome proliferator-activated receptor gamma exacerbates concanavalin A-induced liver injury via suppressing the translocation of NF-κB into the Nucleus Peroxisome proliferator-activated receptor plays an important role in the expression of monocyte chemoattractant protein-1 and neointimal hyperplasia after vascular injury Peroxisome proliferator-activated receptor-γ-mediated polarization of macrophages in leishmania infection Peroxisome proliferator-activator receptor : A link between macrophage CD36 and inflammation in malaria infection Pharmacological and toxicological advances in PPAR-related medicines Pioglitazone attenuates vascular fibrosis in spontaneously hypertensive rats Plasticizers may activate human hepatic peroxisome proliferator-activated receptor α less than that of a mouse but may activate constitutive androstane receptor in liver Prenatal rosiglitazone administration to neonatal rat pups does not alter the adult metabolic phenotype Prostaglandins as PPAR γ modulators in adipogenesis Protection from metabolic dysregulation,obesity,and atherosclerosis by citrus flavonoids: Activation of hepatic PGC1α-mediated fatty acid oxidation Protective effects of peroxisome proliferator-activated receptor-α agonist,Wy14643,on hypoxia/reoxygenation injury in primary rat hepatocytes Regulation of genes involved in carnitine homeostasis by PPAR α across different species (rat,mouse,pig,cattle,chicken,and human) Rhein reduces fat weight in db/db mouse and prevents diet-induced obesity in C57Bl/6 mouse through the inhibition of PPAR γ signaling Role of PPARs in trypanosoma cruzi infection: Implications for chagas disease therapy Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury Signaling crosstalk between PPAR γ and BMP2 in mesenchymal stem cells Solution structures of PPAR γ 2/RXR α complexes TGFβ1 controls PPARγ expression,transcriptional potential,and activity,in part,through Smad3 signaling in murine lung fibroblasts Targeting PPAR γ signaling cascade for the prevention and treatment of prostate cancer The PPAR gamma agonist troglitazone regulates erk 1/2 phosphorylation via a PPARγ-independent,MEK-dependent pathway in human prostate cancer cells The case for the use of PPARγ agonists as an adjunctive therapy for cerebral malaria The current knowledge of the role of PPAR in hepatic ischemia-reperfusion injury The effect of PPAR agonists on the migration of mature and immature eosinophils The impact of PPARγ genetic variants on IBD susceptibility and IBD disease course The interplay of PPARs with parasites and related intracellular pathogens The key to unlocking the chemotherapeutic potential of PPAR ligands: Having the right combination The nitrated fatty acid 10-nitro-oleate diminishes severity of lps-induced acute lung injury in mice The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes The role of PPAR γ in helicobacter pylori infection and gastric carcinogenesis The role of PPARγ in the transcriptional control by agonists and antagonists The role of peroxisome proliferator-activated receptors in colorectal cancer The role of peroxisome proliferator-activated receptors in the esophageal,gastric,and colorectal cancer Time-qualified patterns of variation of PPAR γ,DNMT1,and DNMT3B expression in pancreatic cancer cell lines Transcriptional activity of PGC-1 α and NT-PGC-1 α is differentially regulated by twist-1 in brown fat metabolism Transcriptional regulation by nuclear corepressors and PGC-1 α: Implications for mitochondrial quality control and insulin sensitivity Update on Pparγ and nonalcoholic fatty liver disease